Networks of Centres of Excellence of Canada
Government of Canada

Common menu bar links

Centre for Imaging Technology Commercialization - CIMTEC

$13.3 million for 2011-18
About   |   News   |   Videos
Centre for Imaging Technology Commercialization

Number of partners
30

Partner contributions
$17.9 million

Headquarters
London, Ontario

CEO
Justin Leushner Justin Leushner

Board Chair
Ian Smith Ian Smith,
President, Innovative Biodiagnostics Inc.

Accelerating the commercialization of medical imaging innovations


The opportunity

Canada is home to many of the world’s leading medical imaging research programs. Despite significant public and private investment, however, sales of imaging equipment by Canadian companies continue to represent less than one percent of a $20.6-billion global market—one that is growing by 4% annually. Canada set out to increase its global market share by pooling expertise from across the country to create a critical mass of research, resources and infrastructure. It is also helping developers better understand the complex process of getting their ideas and products to market, and strengthening their capacity to follow through with each step of the process.

How CIMTEC is seizing the opportunity

The Centre for Imaging Technology Commercialization specializes in bringing medical imaging technology to market. By supporting researchers and small and medium-sized companies along the entire product development continuum, CIMTEC facilitates and accelerates the commercialization of medical imaging technologies, bringing them into clinical use faster and more efficiently. CIMTEC’s engineers create hardware and software prototypes. The team helps customers write business plans, connect to funding, and navigate the intellectual property and regulatory landscapes in their target markets. The centre also promotes training and investment in imaging technology through the cultivation of new strategic partnerships between the private sector and academic centres.

Among the results

  • Kingston-based KalGene Pharmaceuticals, Inc. signed a multi-year collaborative agreement with CIMTEC to develop therapeutics and companion diagnostics that specifically target aggressive cancers.
  • Perfint Healthcare in India has been working with CIMTEC to develop a 3D ultrasound-guided focal liver tumour ablation system. The new system will increase the accuracy of identifying and localizing a tumour, and reduce or even eliminate the need for intra-operative CT imaging.
  • Halifax-based Densitas Inc. is seeking U.S. regulatory approval to market a new technology that determines the risk of breast cancer by reliably measuring breast density from digital mammograms. CIMTEC worked with Densitas to develop and validate a robust algorithm, understand options for how to integrate it into clinical workflow, and develop new strategic partnerships.
  • London, Ontario start-up DQE Instruments has operations on three continents and is growing its product line after CIMTEC helped it overcome a mechanical problem – clearing the way for the development of a timely, more usable, cost-efficient device to evaluate the performance of new x-ray imaging systems.
  • CIMTEC recently joined the Canada China Business Council and began translating its marketing materials into Mandarin in an effort to attract Chinese investment in Canadian medical imaging technologies.

Connect with CIMTEC

 

News
December 29, 2016
October 24, 2016
August 3, 2016
Videos
Watch Video
CIMTEC Brings Your Medical Imaging & Digital Pathology Innovation To Market
November 27, 2016
Watch Video
What CIMTEC does for medical imaging device development companies
March 31, 2016
Watch Video
CIMTEC's software and algorithm development capabilities for medical imaging innovations
March 31, 2016
Watch Video
CIMTEC's hardware development capabilities for medical imaging innovations
March 31, 2016